Clinical Trial Detail

NCT ID NCT04303780
Title Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Amgen
Indications

lung non-small cell carcinoma

Therapies

AMG 510

Docetaxel

Age Groups: adult senior

No variant requirements are available.